1. Bagheri, Hadi, Mosallaei, Meysam, Bagherpour, Bahram, Salehi, Ahmad Reza, Salehi, Rasoul. 2020. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. In The journal of gene medicine, 22, e3189. doi:10.1002/jgm.3189. https://pubmed.ncbi.nlm.nih.gov/32196834/
2. Wang, Jie, Xia, Wei, Huang, Yujie, Cao, Zhifei, Zhou, Jian. 2022. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer. In Frontiers in immunology, 13, 1016612. doi:10.3389/fimmu.2022.1016612. https://pubmed.ncbi.nlm.nih.gov/36505458/
3. Gu, Tiezheng, Vasilatos, Shauna N, Yin, Jun, Davidson, Nancy E, Huang, Yi. 2024. Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer. In Cancer letters, 600, 217182. doi:10.1016/j.canlet.2024.217182. https://pubmed.ncbi.nlm.nih.gov/39154703/
4. Guan, Guoying, Xie, Jinjiao, Dai, Yamei, Han, Hui. 2022. TFPI2 suppresses the interaction of TGF-β2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy. In The Journal of biological chemistry, 298, 101725. doi:10.1016/j.jbc.2022.101725. https://pubmed.ncbi.nlm.nih.gov/35157852/
智鼠故事 
